Field Application Scientist at Acute Bioscience | Bioanalytical | Molecular Biology | Protein Engineering
Check out LUNATIC from Unchained Labs. LUNATIC is the next-gen UV/Vis spectrophotometer that makes quantification of biologics easier than ever. You need only 2 µl of volume and 10 minutes to measure 96 samples in a single run, without diluting them. Take a look at its application for determining nucleic acid concentration. #DNA #biologics #genomics #nucleicacid
𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐀𝐮𝐭𝐨𝐢𝐦𝐦𝐮𝐧𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐰𝐢𝐭𝐡 𝐅𝐚𝐛 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 Autoimmune diseases are on the rise, driving demand for advanced treatments. This has spurred innovation in biologic therapies, including bispecific antibodies. In this exclusive article, Gardiner Smith and Chia Chia Sun discuss how Fab Biopharma is shaping the future of autoimmune treatments. Read the full article here: https://lnkd.in/e27t4AUB #AutoimmuneDisease #Biologics #Antibody #Biopharma #Innovation
Shares of uniQure surged more than 70% after it reported encouraging interim data from ongoing mid-stage studies of its #HuntingtonsDisease #genetherapy AMT-130, which demonstrated a significant slowing of disease progression at two years post-treatment. https://lnkd.in/g6nzSTcm #biotechnology #clinicalresearch #genetics #orphandrugs #pharmaceuticals #uniQure
Little teaser for next week - we'll be launching our full agenda for the Festival of Biologics to download! This version is set up for easy navigation and allows you to see all of the content at a glance - we currently have more than 250 great speakers giving presentations and leading panels, roundtable discussions and more that we don't want you to miss! You can of course keep up to date with the latest speakers and sessions on our website until then, but keep an eye out for the announcement from our official account next week! #festivalofbiologics #biologics #antibodies #immunotherapy #biosimilars #clinicaltrials #bioprocessing
New blog today showing off a use case written by Jessica, our Head of Business Development! In this example of how we work with customers, Bridge Informatics helped a pharmaceutical company perform strain-level bacterial classification (strain abundance analysis) for regulatory approval of their new immunotherapy product by analyzing whole genome sequencing data, leading to the identification of a predominant bacterial strain and speeding up the product development timeline. Let us know if you need support on a similar project! #bioinformatics #pharma #WGS
When our client needed to perform strain-level bacterial taxonomic classification as part of an essential component for regulatory approval of their new immunotherapy product, we quickly leveraged our team's expertise in #wholegenome #metagenomic #sequencing analysis, contributing to a smooth FDA approval process. Read the full case study on our blog: https://lnkd.in/efBxEQug #bioinformatics #genomics #pharma #regulatoryaffairs
Last week, the #FDA approved its 60th #biosimilar since the start of the biosimilars program. Learn more here: https://lnkd.in/g4baZK65 #Biologics #DrugDevelopment
The field of #biologics is growing and transforming thanks to various advancements. Check out what Anupreet Kaur from National Institute of Standards and Technology (NIST) and Peter Timmerman and Hans de Backer from Biosynth had to say on the subject in May's Cover Story: https://lnkd.in/eUWJQ6hS
Bispecific antibodies are gaining popularity for their promise as targeted treatments for oncological, rare, and chronic disease indications. However, the complexity of these molecules makes their development and manufacturing a challenge. Learn how Enzene optimized the manufacturing of a complex biologic molecule to achieve an 8x increase in productivity over a fed-batch process. Link to the full case study: https://lnkd.in/dBwK_FiW #bispecifics #antibodies #biologics #EnzeneCaseStudy
Maria Cidinaria Silva Alves, et al. recent research was published in International Journal of #Molecular #Biology Open Access the article explains about “the family of α-hairpinin antimicrobial peptides” which was recently discovered in plants. https://lnkd.in/gjSxm5XH #bioinformatics #genomics #antimicrobial #pharmaceuticals #enzymes
Big things are happening in the world of Biopharma! This fall, we dive deep into important topics such as Micro, mRNA, Mycoplasma, and more! 📰 Don't miss out on the latest trends and insights shaping the industry. Dive deeper into our latest insights by reading the complete newsletter here: https://okt.to/B0zwCo #Eurofins #BioPharma #Newsletter #Microbiology #mRNA #Mycoplasma
Accurately assessing immunogenicity is vital in the development of biologic therapeutics. Abzena’s EpiScreen™ 2.0.platform is a set of in silico, proteomic and cell-based assays that offer a comprehensive solution for predicting and evaluating T-cell epitopes, allowing you to determine the immunogenic potential of your biologic candidates. EpiScreen™ 2.0 provides detailed insights into the immune response. It enables you to identify and mitigate immunogenicity risks early in the development process, ensuring safer and more effective therapies. Learn how EpiScreen™ 2.0 can enhance your biologic development by minimizing immunogenicity risks: https://lnkd.in/er9PNz_4 #Immunogenicity #Biologics #DrugDevelopment #Biotechnology #CRO #CDMO